Second phase 3 trial shows sustained benefit and supports forthcoming regulatory submission
Source: PharmaTimes
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.